SCHEMBL9527853

SCHEMBL9527853

COCCOCOCC(O)COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TK1 P04183 2/20 0.40
CTSK P43235 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KIF11 P52732 1/20 0.38
MAPT P10636 1/20 0.37
CA1 P00915 3/20 0.34
DUT P33316 2/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33
TK2 O00142 1/20 0.33
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9527858 1.00 TK1 (0.40) TK1CTSKALDH1A1KDM4EKIF11
SCHEMBL15827068 0.85 MAPT (0.49) TK1CTSKKIF11MAPTDUT
SCHEMBL10411750 0.80 SLC6A1 (0.39) TK1ALDH1A1KDM4EKIF11
SCHEMBL2111572 0.80 KIF11 (0.50) TK1CTSKALDH1A1KIF11MAPT
SCHEMBL3485608 0.77 KIF11 (0.50) TK1CTSKALDH1A1KDM4EKIF11
SCHEMBL19522241 0.77 SLC6A1 (0.44) TK1KIF11MAPT
SCHEMBL9637986 0.76 USP2 (0.47) TK1CTSKALDH1A1KDM4EKIF11
SCHEMBL25243275 0.75 USP2 (0.50) TK1CTSKALDH1A1KDM4EKIF11
SCHEMBL2220171 0.75 USP2 (0.50) TK1CTSKALDH1A1KDM4EKIF11
SCHEMBL25289434 0.75 USP2 (0.50) TK1CTSKALDH1A1KDM4EKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0238202-B1 GLYCEROL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE Sankyo Company Limited (JP) 1993-04-28 EP disclosed
US-5068340-A Antagonist of platelet activating factor for treatment of asthma, inflammation or shock SANKYO COMPANY, LIMITED (JP) 1991-11-26 US disclosed